Skip to content

Zepbound Injection Site Reactions: Clinical Data, Causes & How to Keep Them Under Control

Injection site reactions on Zepbound are uncommon, and they usually show up as a little redness, itching or bruising where the shot went in. In clinical trials of Zepbound (tirzepatide), 6–8% of people had one, compared with 2% on placebo, so more than 9 in 10 people never did (Zepbound prescribing information). Glapp, the GLP-1 tracker, lets you log any reaction on shot day right next to your Zepbound dose, so you can see shot by shot whether they're fading.

Key numbers

Number What it means
6–8% of people on Zepbound had an injection site reaction in its weight-loss trials, vs 2% on placebo
5,391 users currently tracking Zepbound-related injection site reactions in Glapp

Zepbound injection site reactions: what the clinical evidence shows

Zepbound's prescribing information pools two placebo-controlled weight-loss trials of tirzepatide, with 958 people on placebo and 2,519 on Zepbound:

Side effect Placebo 5 mg 10 mg 15 mg
Injection site reactions*2%6%8%8%
Hypersensitivity (allergic) reactions3%5%5%5%

*Includes bruising, redness (erythema), itching (pruritus), pain, rash and general reaction at the injection site. Source: Zepbound prescribing information, Table 1 and section 6.1.

The tirzepatide trial data add one detail most guides miss: injection site reactions were reported in 11.3% of people who developed antibodies to tirzepatide, Zepbound's active ingredient, compared with 1% of those who didn't.

Why does Zepbound cause injection site reactions?

Zepbound's prescribing information groups several local reactions together and points to the immune response as a factor: people whose bodies made antibodies to tirzepatide were about ten times more likely to have one. Most reactions it describes are local and mild, such as bruising, redness or itching.

A local reaction is different from an allergic reaction. The prescribing information for this GLP-1 medication reports severe allergic reactions in 0.1% of people on Zepbound, and post-marketing reports of anaphylaxis and swelling of the face, lips or throat. Those need emergency care.

Your Glapp check-ins show whether reactions happen with every shot or only some, and whether they're getting milder.

Rotating sites, and telling a reaction from an allergy

  • Rotate where you inject. The instructions tell you to use a different spot each week: your stomach (at least 2 inches from your belly button), your thigh, or the back of your upper arm if someone else injects. Using the same spot again and again makes reactions more likely.
  • What a normal reaction looks like. Redness, itching, mild pain, a small bruise or a little bump right where the needle went in. It stays at the site and fades on its own.
  • What an allergic reaction looks like. Hives or a rash spreading beyond the site, swelling of your face, lips, tongue or throat, trouble breathing or feeling faint. That's an emergency: get help straight away.

Track your Zepbound injection site reactions with a GLP-1 tracker app

A reaction after one shot can be worrying; four shots side by side tell you what's really going on. That's what a GLP-1 tracker is for: log your injection site on shot day and the day after, and you're in control. You'll know how often reactions happen, how strong they are, how long they last and whether they're fading.

Why Glapp? It's a top-rated GLP-1 tracker used by 100,000+ people, rated 4.8/5 on Trustpilot and the App Store, and 4.6/5 on Google Play. Glapp grew out of Reddit GLP-1 support groups and is built by developers who are GLP-1 users themselves, so most features come straight from community requests. Its features are grounded in peer-reviewed research and published clinical trial data, core tracking is free, and it works on iPhone, Android and web with your data synced across devices. Here's how to use it over your next four shots.

Glapp does not provide medical advice or treat side effects. It shows your daily check-ins against your estimated medication levels so you have structured data to share with your prescriber.

Shot 1: Start tracking your injection site reactions

Use Glapp's daily check-in to record any injection site reaction on shot day and rate how severe it feels. Check in again the next day so you capture how long it lasts.

These entries help you see whether reactions are getting better, getting worse or staying the same from one shot to the next. You'll have a clear record without having to remember each one.

Daily check-in
Injection site reactions · Med

Shot 2: See how your reactions change over time

Open the side-effects chart in the Progress tab and choose the period you want to review. Your ratings appear on a timeline next to your shots, making it easier to see whether a bad reaction was a one-off or part of a pattern.

Progress, side-effects chart, two shots
Injection site reactions · Low

Shot 3: Look for patterns in your weekly report

Glapp's weekly progress report brings your logged data together, with dedicated sections showing your side effects and how they change.

Do reactions show up with every shot or only some? Do they last one day or several? Are they getting milder? Reviewing several shots side by side can help you spot patterns that are easy to miss, and give you specific questions to discuss with your doctor.

Weekly progress report
Injection site reactions · Low

Shot 4: Bring a clear record to your doctor

After four shots, review the bigger picture: are reactions becoming less frequent, staying the same or getting worse?

Create a doctor's report in Glapp and choose the information to include. Your doctor can review your symptom history alongside your doses and progress, giving you a more focused conversation about your treatment and your injection technique.

Doctor's report

Start tracking your Zepbound shots in Glapp

Injection site reactions at higher doses: 5 mg vs 10 and 15 mg

Zepbound starts at 2.5 mg for four weeks, then steps up by 2.5 mg at least four weeks apart, to a maintenance dose of 5, 10 or 15 mg. Reactions were reported in 6% at 5 mg and 8% at both 10 mg and 15 mg, a small step up after the first maintenance dose.

Log every shot through each step; your weekly progress report will show whether reactions changed with the new dose.

See every dose in the Zepbound dosage chart and check your pen with Zepbound pen clicks.

What to bring to your prescriber

A shot-by-shot log shows your prescriber the pattern at a glance:

Shot date Dose Reaction on shot day Still there day 2? Type Other side effects logged
Example Sun 1 Nov 10 mgMedYesRedness, itchingNone
Example Sun 8 Nov 10 mgLowNoRednessNone
Example Sun 15 Nov 10 mgLowNoBruisingNausea
Example Sun 22 Nov 10 mgNone loggedNo–None

Questions you could ask. They're conversation starters, not recommendations; your prescriber decides what, if anything, to change.

  • "I get redness and itching after most shots. Is that the kind of reaction you'd expect?"
  • "Could you check that my injection technique is right?"
  • "How do I tell a normal injection site reaction from an allergic one?"

Frequently asked questions

What does a Zepbound injection site reaction look like?

Zepbound's prescribing information lists bruising, redness, itching, pain, rash and general reaction at the injection site. Swelling of the face, lips or throat, or trouble breathing, is not a local reaction and needs emergency care.

How long do Zepbound injection site reactions last?

Most injection site reactions are mild and short-lived, fading on their own within a few days, and rotating where you inject each week helps. If a reaction keeps growing, spreads, feels hot or lasts more than a week, show it to your prescriber.

Are injection site reactions more common at higher Zepbound doses?

Slightly: 6% at 5 mg and 8% at 10 and 15 mg, compared with 2% on placebo.

How do I track Zepbound injection site reactions?

Log the reaction in Glapp's daily check-in on shot day and the day after, rating it low, medium or high. Progress and your weekly reports show whether reactions are fading shot to shot.

About the data

Ratings are self-reported and medication levels are estimated from dose and timing, not measured. This page is for information only and is not medical advice; talk to your prescriber about any side effect.

About the author

We're GLP-1 patients and health tech professionals, building Glapp in collaboration with doctors. About us

Sources